nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—kidney cancer	0.292	1	CbGaD
Posaconazole—ABCB1—Temsirolimus—kidney cancer	0.0602	0.134	CbGbCtD
Posaconazole—CYP3A4—Everolimus—kidney cancer	0.0534	0.119	CbGbCtD
Posaconazole—CYP3A4—Temsirolimus—kidney cancer	0.0361	0.0802	CbGbCtD
Posaconazole—ABCB1—Pazopanib—kidney cancer	0.0316	0.0704	CbGbCtD
Posaconazole—ABCB1—Dactinomycin—kidney cancer	0.0289	0.0643	CbGbCtD
Posaconazole—ABCB1—Gemcitabine—kidney cancer	0.0229	0.0509	CbGbCtD
Posaconazole—ABCB1—Erlotinib—kidney cancer	0.0226	0.0502	CbGbCtD
Posaconazole—ABCB1—Paclitaxel—kidney cancer	0.0207	0.046	CbGbCtD
Posaconazole—CYP3A4—Pazopanib—kidney cancer	0.0189	0.0422	CbGbCtD
Posaconazole—ABCB1—Sorafenib—kidney cancer	0.0183	0.0408	CbGbCtD
Posaconazole—ABCB1—Vinblastine—kidney cancer	0.0181	0.0403	CbGbCtD
Posaconazole—ABCB1—Vincristine—kidney cancer	0.0178	0.0396	CbGbCtD
Posaconazole—ABCB1—Sunitinib—kidney cancer	0.0149	0.0331	CbGbCtD
Posaconazole—CYP3A4—Erlotinib—kidney cancer	0.0135	0.0301	CbGbCtD
Posaconazole—CYP3A4—Paclitaxel—kidney cancer	0.0124	0.0275	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—kidney cancer	0.0111	0.0248	CbGbCtD
Posaconazole—CYP3A4—Sorafenib—kidney cancer	0.011	0.0245	CbGbCtD
Posaconazole—CYP3A4—Vinblastine—kidney cancer	0.0109	0.0241	CbGbCtD
Posaconazole—CYP3A4—Vincristine—kidney cancer	0.0107	0.0237	CbGbCtD
Posaconazole—CYP3A4—Sunitinib—kidney cancer	0.00891	0.0198	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—kidney cancer	0.00667	0.0148	CbGbCtD
Posaconazole—Itraconazole—CYP1A1—kidney cancer	0.000943	0.408	CrCbGaD
Posaconazole—Ketoconazole—CYP1A1—kidney cancer	0.000565	0.245	CrCbGaD
Posaconazole—Itraconazole—ABCB1—kidney cancer	0.000501	0.217	CrCbGaD
Posaconazole—Ketoconazole—ABCB1—kidney cancer	0.0003	0.13	CrCbGaD
Posaconazole—Liver function test abnormal—Doxorubicin—kidney cancer	4.29e-05	0.000167	CcSEcCtD
Posaconazole—Infection—Paclitaxel—kidney cancer	4.29e-05	0.000167	CcSEcCtD
Posaconazole—Flatulence—Capecitabine—kidney cancer	4.28e-05	0.000167	CcSEcCtD
Posaconazole—Dry skin—Doxorubicin—kidney cancer	4.26e-05	0.000166	CcSEcCtD
Posaconazole—Dysgeusia—Capecitabine—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Dizziness—Sunitinib—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Feeling abnormal—Gemcitabine—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Shock—Paclitaxel—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Vomiting—Sorafenib—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Abdominal pain upper—Doxorubicin—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Orthostatic hypotension—Doxorubicin—kidney cancer	4.25e-05	0.000166	CcSEcCtD
Posaconazole—Nervous system disorder—Paclitaxel—kidney cancer	4.24e-05	0.000165	CcSEcCtD
Posaconazole—Hypokalaemia—Doxorubicin—kidney cancer	4.23e-05	0.000165	CcSEcCtD
Posaconazole—Thrombocytopenia—Paclitaxel—kidney cancer	4.23e-05	0.000165	CcSEcCtD
Posaconazole—Tachycardia—Paclitaxel—kidney cancer	4.21e-05	0.000164	CcSEcCtD
Posaconazole—Rash—Sorafenib—kidney cancer	4.21e-05	0.000164	CcSEcCtD
Posaconazole—Dermatitis—Sorafenib—kidney cancer	4.21e-05	0.000164	CcSEcCtD
Posaconazole—Back pain—Capecitabine—kidney cancer	4.2e-05	0.000164	CcSEcCtD
Posaconazole—Breast disorder—Doxorubicin—kidney cancer	4.2e-05	0.000164	CcSEcCtD
Posaconazole—Skin disorder—Paclitaxel—kidney cancer	4.19e-05	0.000164	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.19e-05	0.000163	CcSEcCtD
Posaconazole—Headache—Sorafenib—kidney cancer	4.19e-05	0.000163	CcSEcCtD
Posaconazole—Muscle spasms—Capecitabine—kidney cancer	4.17e-05	0.000163	CcSEcCtD
Posaconazole—Hyperhidrosis—Paclitaxel—kidney cancer	4.17e-05	0.000163	CcSEcCtD
Posaconazole—Diarrhoea—Dactinomycin—kidney cancer	4.16e-05	0.000162	CcSEcCtD
Posaconazole—Nasopharyngitis—Doxorubicin—kidney cancer	4.16e-05	0.000162	CcSEcCtD
Posaconazole—Anorexia—Paclitaxel—kidney cancer	4.12e-05	0.00016	CcSEcCtD
Posaconazole—Gastritis—Doxorubicin—kidney cancer	4.11e-05	0.00016	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.1e-05	0.00016	CcSEcCtD
Posaconazole—Muscular weakness—Doxorubicin—kidney cancer	4.1e-05	0.00016	CcSEcCtD
Posaconazole—Vision blurred—Capecitabine—kidney cancer	4.09e-05	0.00016	CcSEcCtD
Posaconazole—Vomiting—Sunitinib—kidney cancer	4.09e-05	0.000159	CcSEcCtD
Posaconazole—Body temperature increased—Gemcitabine—kidney cancer	4.08e-05	0.000159	CcSEcCtD
Posaconazole—Tremor—Capecitabine—kidney cancer	4.07e-05	0.000159	CcSEcCtD
Posaconazole—Rash—Sunitinib—kidney cancer	4.05e-05	0.000158	CcSEcCtD
Posaconazole—Dermatitis—Sunitinib—kidney cancer	4.05e-05	0.000158	CcSEcCtD
Posaconazole—Abdominal distension—Doxorubicin—kidney cancer	4.04e-05	0.000158	CcSEcCtD
Posaconazole—Hypotension—Paclitaxel—kidney cancer	4.04e-05	0.000157	CcSEcCtD
Posaconazole—Ill-defined disorder—Capecitabine—kidney cancer	4.03e-05	0.000157	CcSEcCtD
Posaconazole—Headache—Sunitinib—kidney cancer	4.03e-05	0.000157	CcSEcCtD
Posaconazole—Dysphagia—Doxorubicin—kidney cancer	4.02e-05	0.000157	CcSEcCtD
Posaconazole—Anaemia—Capecitabine—kidney cancer	4.01e-05	0.000156	CcSEcCtD
Posaconazole—Hypersensitivity—Vincristine—kidney cancer	4.01e-05	0.000156	CcSEcCtD
Posaconazole—Eosinophilia—Doxorubicin—kidney cancer	3.98e-05	0.000155	CcSEcCtD
Posaconazole—Nausea—Sorafenib—kidney cancer	3.97e-05	0.000155	CcSEcCtD
Posaconazole—Pancreatitis—Doxorubicin—kidney cancer	3.94e-05	0.000154	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.93e-05	0.000153	CcSEcCtD
Posaconazole—Malaise—Capecitabine—kidney cancer	3.92e-05	0.000153	CcSEcCtD
Posaconazole—Insomnia—Paclitaxel—kidney cancer	3.91e-05	0.000152	CcSEcCtD
Posaconazole—Vertigo—Capecitabine—kidney cancer	3.9e-05	0.000152	CcSEcCtD
Posaconazole—Asthenia—Vincristine—kidney cancer	3.9e-05	0.000152	CcSEcCtD
Posaconazole—Syncope—Capecitabine—kidney cancer	3.89e-05	0.000152	CcSEcCtD
Posaconazole—Leukopenia—Capecitabine—kidney cancer	3.89e-05	0.000152	CcSEcCtD
Posaconazole—Paraesthesia—Paclitaxel—kidney cancer	3.88e-05	0.000151	CcSEcCtD
Posaconazole—Vomiting—Dactinomycin—kidney cancer	3.87e-05	0.000151	CcSEcCtD
Posaconazole—Dyspnoea—Paclitaxel—kidney cancer	3.85e-05	0.00015	CcSEcCtD
Posaconazole—Somnolence—Paclitaxel—kidney cancer	3.84e-05	0.00015	CcSEcCtD
Posaconazole—Rash—Dactinomycin—kidney cancer	3.84e-05	0.00015	CcSEcCtD
Posaconazole—Nausea—Sunitinib—kidney cancer	3.82e-05	0.000149	CcSEcCtD
Posaconazole—Loss of consciousness—Capecitabine—kidney cancer	3.82e-05	0.000149	CcSEcCtD
Posaconazole—Pancytopenia—Doxorubicin—kidney cancer	3.82e-05	0.000149	CcSEcCtD
Posaconazole—Dyspepsia—Paclitaxel—kidney cancer	3.8e-05	0.000148	CcSEcCtD
Posaconazole—Cough—Capecitabine—kidney cancer	3.79e-05	0.000148	CcSEcCtD
Posaconazole—Neutropenia—Doxorubicin—kidney cancer	3.76e-05	0.000146	CcSEcCtD
Posaconazole—Dysuria—Doxorubicin—kidney cancer	3.76e-05	0.000146	CcSEcCtD
Posaconazole—Decreased appetite—Paclitaxel—kidney cancer	3.75e-05	0.000146	CcSEcCtD
Posaconazole—Hypertension—Capecitabine—kidney cancer	3.75e-05	0.000146	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.73e-05	0.000146	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.73e-05	0.000145	CcSEcCtD
Posaconazole—Fatigue—Paclitaxel—kidney cancer	3.72e-05	0.000145	CcSEcCtD
Posaconazole—Diarrhoea—Vincristine—kidney cancer	3.72e-05	0.000145	CcSEcCtD
Posaconazole—Pollakiuria—Doxorubicin—kidney cancer	3.71e-05	0.000145	CcSEcCtD
Posaconazole—Asthenia—Gemcitabine—kidney cancer	3.7e-05	0.000144	CcSEcCtD
Posaconazole—Chest pain—Capecitabine—kidney cancer	3.7e-05	0.000144	CcSEcCtD
Posaconazole—Arthralgia—Capecitabine—kidney cancer	3.7e-05	0.000144	CcSEcCtD
Posaconazole—Myalgia—Capecitabine—kidney cancer	3.7e-05	0.000144	CcSEcCtD
Posaconazole—Pain—Paclitaxel—kidney cancer	3.69e-05	0.000144	CcSEcCtD
Posaconazole—Constipation—Paclitaxel—kidney cancer	3.69e-05	0.000144	CcSEcCtD
Posaconazole—Anxiety—Capecitabine—kidney cancer	3.68e-05	0.000144	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.67e-05	0.000143	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—kidney cancer	3.66e-05	0.000143	CcSEcCtD
Posaconazole—Discomfort—Capecitabine—kidney cancer	3.65e-05	0.000142	CcSEcCtD
Posaconazole—Pruritus—Gemcitabine—kidney cancer	3.65e-05	0.000142	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—kidney cancer	3.63e-05	0.000142	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—kidney cancer	3.62e-05	0.000141	CcSEcCtD
Posaconazole—Dry mouth—Capecitabine—kidney cancer	3.62e-05	0.000141	CcSEcCtD
Posaconazole—Nausea—Dactinomycin—kidney cancer	3.61e-05	0.000141	CcSEcCtD
Posaconazole—Pneumonia—Doxorubicin—kidney cancer	3.6e-05	0.00014	CcSEcCtD
Posaconazole—Dizziness—Vincristine—kidney cancer	3.6e-05	0.00014	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—kidney cancer	3.58e-05	0.00014	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—kidney cancer	3.58e-05	0.00014	CcSEcCtD
Posaconazole—Confusional state—Capecitabine—kidney cancer	3.57e-05	0.000139	CcSEcCtD
Posaconazole—Feeling abnormal—Paclitaxel—kidney cancer	3.56e-05	0.000139	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.55e-05	0.000138	CcSEcCtD
Posaconazole—Oedema—Capecitabine—kidney cancer	3.54e-05	0.000138	CcSEcCtD
Posaconazole—Gastrointestinal pain—Paclitaxel—kidney cancer	3.53e-05	0.000138	CcSEcCtD
Posaconazole—Diarrhoea—Gemcitabine—kidney cancer	3.53e-05	0.000138	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—kidney cancer	3.52e-05	0.000137	CcSEcCtD
Posaconazole—Infection—Capecitabine—kidney cancer	3.52e-05	0.000137	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—kidney cancer	3.51e-05	0.000137	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—kidney cancer	3.49e-05	0.000136	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—kidney cancer	3.49e-05	0.000136	CcSEcCtD
Posaconazole—Shock—Capecitabine—kidney cancer	3.49e-05	0.000136	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—kidney cancer	3.48e-05	0.000136	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—kidney cancer	3.48e-05	0.000136	CcSEcCtD
Posaconazole—Nervous system disorder—Capecitabine—kidney cancer	3.48e-05	0.000136	CcSEcCtD
Posaconazole—Thrombocytopenia—Capecitabine—kidney cancer	3.47e-05	0.000135	CcSEcCtD
Posaconazole—Tachycardia—Capecitabine—kidney cancer	3.46e-05	0.000135	CcSEcCtD
Posaconazole—Vomiting—Vincristine—kidney cancer	3.46e-05	0.000135	CcSEcCtD
Posaconazole—Skin disorder—Capecitabine—kidney cancer	3.44e-05	0.000134	CcSEcCtD
Posaconazole—Urticaria—Paclitaxel—kidney cancer	3.43e-05	0.000134	CcSEcCtD
Posaconazole—Rash—Vincristine—kidney cancer	3.43e-05	0.000134	CcSEcCtD
Posaconazole—Hyperhidrosis—Capecitabine—kidney cancer	3.43e-05	0.000134	CcSEcCtD
Posaconazole—Dermatitis—Vincristine—kidney cancer	3.43e-05	0.000134	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—kidney cancer	3.42e-05	0.000133	CcSEcCtD
Posaconazole—Body temperature increased—Paclitaxel—kidney cancer	3.41e-05	0.000133	CcSEcCtD
Posaconazole—Abdominal pain—Paclitaxel—kidney cancer	3.41e-05	0.000133	CcSEcCtD
Posaconazole—Headache—Vincristine—kidney cancer	3.41e-05	0.000133	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—kidney cancer	3.39e-05	0.000132	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—kidney cancer	3.38e-05	0.000132	CcSEcCtD
Posaconazole—Anorexia—Capecitabine—kidney cancer	3.38e-05	0.000132	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—kidney cancer	3.36e-05	0.000131	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—kidney cancer	3.34e-05	0.00013	CcSEcCtD
Posaconazole—Hypotension—Capecitabine—kidney cancer	3.31e-05	0.000129	CcSEcCtD
Posaconazole—Vomiting—Gemcitabine—kidney cancer	3.28e-05	0.000128	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—kidney cancer	3.27e-05	0.000128	CcSEcCtD
Posaconazole—Rash—Gemcitabine—kidney cancer	3.25e-05	0.000127	CcSEcCtD
Posaconazole—Dermatitis—Gemcitabine—kidney cancer	3.25e-05	0.000127	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—kidney cancer	3.23e-05	0.000126	CcSEcCtD
Posaconazole—Headache—Gemcitabine—kidney cancer	3.23e-05	0.000126	CcSEcCtD
Posaconazole—Nausea—Vincristine—kidney cancer	3.23e-05	0.000126	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.23e-05	0.000126	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—kidney cancer	3.22e-05	0.000126	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—kidney cancer	3.22e-05	0.000125	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—kidney cancer	3.22e-05	0.000125	CcSEcCtD
Posaconazole—Insomnia—Capecitabine—kidney cancer	3.21e-05	0.000125	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—kidney cancer	3.2e-05	0.000125	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—kidney cancer	3.19e-05	0.000124	CcSEcCtD
Posaconazole—Paraesthesia—Capecitabine—kidney cancer	3.18e-05	0.000124	CcSEcCtD
Posaconazole—Hypersensitivity—Paclitaxel—kidney cancer	3.18e-05	0.000124	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—kidney cancer	3.18e-05	0.000124	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—kidney cancer	3.17e-05	0.000123	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—kidney cancer	3.16e-05	0.000123	CcSEcCtD
Posaconazole—Dyspnoea—Capecitabine—kidney cancer	3.16e-05	0.000123	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—kidney cancer	3.15e-05	0.000123	CcSEcCtD
Posaconazole—Dyspepsia—Capecitabine—kidney cancer	3.12e-05	0.000122	CcSEcCtD
Posaconazole—Asthenia—Paclitaxel—kidney cancer	3.1e-05	0.000121	CcSEcCtD
Posaconazole—Decreased appetite—Capecitabine—kidney cancer	3.08e-05	0.00012	CcSEcCtD
Posaconazole—Nausea—Gemcitabine—kidney cancer	3.06e-05	0.000119	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Capecitabine—kidney cancer	3.06e-05	0.000119	CcSEcCtD
Posaconazole—Fatigue—Capecitabine—kidney cancer	3.06e-05	0.000119	CcSEcCtD
Posaconazole—Pruritus—Paclitaxel—kidney cancer	3.06e-05	0.000119	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—kidney cancer	3.04e-05	0.000119	CcSEcCtD
Posaconazole—Constipation—Capecitabine—kidney cancer	3.03e-05	0.000118	CcSEcCtD
Posaconazole—Pain—Capecitabine—kidney cancer	3.03e-05	0.000118	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—kidney cancer	3.01e-05	0.000117	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—kidney cancer	3e-05	0.000117	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—kidney cancer	2.98e-05	0.000116	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—kidney cancer	2.98e-05	0.000116	CcSEcCtD
Posaconazole—Diarrhoea—Paclitaxel—kidney cancer	2.95e-05	0.000115	CcSEcCtD
Posaconazole—Feeling abnormal—Capecitabine—kidney cancer	2.92e-05	0.000114	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—kidney cancer	2.92e-05	0.000114	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—kidney cancer	2.9e-05	0.000113	CcSEcCtD
Posaconazole—Gastrointestinal pain—Capecitabine—kidney cancer	2.9e-05	0.000113	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—kidney cancer	2.9e-05	0.000113	CcSEcCtD
Posaconazole—Chills—Doxorubicin—kidney cancer	2.89e-05	0.000112	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—kidney cancer	2.87e-05	0.000112	CcSEcCtD
Posaconazole—Dizziness—Paclitaxel—kidney cancer	2.86e-05	0.000111	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—kidney cancer	2.84e-05	0.000111	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—kidney cancer	2.82e-05	0.00011	CcSEcCtD
Posaconazole—Urticaria—Capecitabine—kidney cancer	2.82e-05	0.00011	CcSEcCtD
Posaconazole—Abdominal pain—Capecitabine—kidney cancer	2.8e-05	0.000109	CcSEcCtD
Posaconazole—Body temperature increased—Capecitabine—kidney cancer	2.8e-05	0.000109	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—kidney cancer	2.8e-05	0.000109	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—kidney cancer	2.8e-05	0.000109	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—kidney cancer	2.76e-05	0.000108	CcSEcCtD
Posaconazole—Vomiting—Paclitaxel—kidney cancer	2.75e-05	0.000107	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—kidney cancer	2.74e-05	0.000107	CcSEcCtD
Posaconazole—Rash—Paclitaxel—kidney cancer	2.72e-05	0.000106	CcSEcCtD
Posaconazole—Dermatitis—Paclitaxel—kidney cancer	2.72e-05	0.000106	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—kidney cancer	2.71e-05	0.000106	CcSEcCtD
Posaconazole—Headache—Paclitaxel—kidney cancer	2.71e-05	0.000105	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—kidney cancer	2.69e-05	0.000105	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—kidney cancer	2.64e-05	0.000103	CcSEcCtD
Posaconazole—Hypersensitivity—Capecitabine—kidney cancer	2.61e-05	0.000102	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—kidney cancer	2.6e-05	0.000101	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—kidney cancer	2.59e-05	0.000101	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—kidney cancer	2.57e-05	0.0001	CcSEcCtD
Posaconazole—Nausea—Paclitaxel—kidney cancer	2.57e-05	0.0001	CcSEcCtD
Posaconazole—Asthenia—Capecitabine—kidney cancer	2.54e-05	9.91e-05	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—kidney cancer	2.52e-05	9.84e-05	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—kidney cancer	2.51e-05	9.8e-05	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—kidney cancer	2.51e-05	9.79e-05	CcSEcCtD
Posaconazole—Pruritus—Capecitabine—kidney cancer	2.51e-05	9.78e-05	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—kidney cancer	2.51e-05	9.77e-05	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—kidney cancer	2.46e-05	9.59e-05	CcSEcCtD
Posaconazole—Cough—Doxorubicin—kidney cancer	2.44e-05	9.52e-05	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—kidney cancer	2.43e-05	9.46e-05	CcSEcCtD
Posaconazole—Diarrhoea—Capecitabine—kidney cancer	2.42e-05	9.45e-05	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—kidney cancer	2.42e-05	9.42e-05	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—kidney cancer	2.38e-05	9.29e-05	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—kidney cancer	2.38e-05	9.29e-05	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—kidney cancer	2.38e-05	9.29e-05	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—kidney cancer	2.37e-05	9.26e-05	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.37e-05	9.23e-05	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—kidney cancer	2.35e-05	9.18e-05	CcSEcCtD
Posaconazole—Dizziness—Capecitabine—kidney cancer	2.34e-05	9.14e-05	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—kidney cancer	2.33e-05	9.09e-05	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—kidney cancer	2.3e-05	8.98e-05	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—kidney cancer	2.28e-05	8.91e-05	CcSEcCtD
Posaconazole—Infection—Doxorubicin—kidney cancer	2.27e-05	8.85e-05	CcSEcCtD
Posaconazole—Vomiting—Capecitabine—kidney cancer	2.25e-05	8.79e-05	CcSEcCtD
Posaconazole—Shock—Doxorubicin—kidney cancer	2.25e-05	8.76e-05	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—kidney cancer	2.24e-05	8.73e-05	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—kidney cancer	2.24e-05	8.72e-05	CcSEcCtD
Posaconazole—Rash—Capecitabine—kidney cancer	2.23e-05	8.71e-05	CcSEcCtD
Posaconazole—Dermatitis—Capecitabine—kidney cancer	2.23e-05	8.7e-05	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—kidney cancer	2.23e-05	8.69e-05	CcSEcCtD
Posaconazole—Headache—Capecitabine—kidney cancer	2.22e-05	8.66e-05	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—kidney cancer	2.22e-05	8.65e-05	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—kidney cancer	2.21e-05	8.61e-05	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—kidney cancer	2.18e-05	8.49e-05	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—kidney cancer	2.13e-05	8.32e-05	CcSEcCtD
Posaconazole—Nausea—Capecitabine—kidney cancer	2.11e-05	8.21e-05	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.08e-05	8.11e-05	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—kidney cancer	2.07e-05	8.06e-05	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—kidney cancer	2.05e-05	8e-05	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—kidney cancer	2.04e-05	7.94e-05	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—kidney cancer	2.03e-05	7.92e-05	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—kidney cancer	2.01e-05	7.84e-05	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—kidney cancer	1.99e-05	7.74e-05	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.97e-05	7.69e-05	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—kidney cancer	1.97e-05	7.68e-05	CcSEcCtD
Posaconazole—Pain—Doxorubicin—kidney cancer	1.95e-05	7.62e-05	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—kidney cancer	1.95e-05	7.62e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—kidney cancer	1.88e-05	7.34e-05	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—kidney cancer	1.87e-05	7.28e-05	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—kidney cancer	1.81e-05	7.08e-05	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—kidney cancer	1.81e-05	7.04e-05	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—kidney cancer	1.81e-05	7.04e-05	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—kidney cancer	1.68e-05	6.56e-05	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—kidney cancer	1.64e-05	6.39e-05	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—kidney cancer	1.62e-05	6.3e-05	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—kidney cancer	1.56e-05	6.09e-05	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—kidney cancer	1.51e-05	5.89e-05	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—kidney cancer	1.45e-05	5.66e-05	CcSEcCtD
Posaconazole—Rash—Doxorubicin—kidney cancer	1.44e-05	5.62e-05	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—kidney cancer	1.44e-05	5.61e-05	CcSEcCtD
Posaconazole—Headache—Doxorubicin—kidney cancer	1.43e-05	5.58e-05	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—kidney cancer	1.36e-05	5.29e-05	CcSEcCtD
